{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002956","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2026-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.558775+00:00","generated_at":"2026-05-16T09:18:08.838984+00:00","sec_items":["8.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Regen Biopharma declares 1:1 dividend of Series A Preferred stock for all share classes","bullets":["Board declared dividend of one share of Series A Preferred for each share of Common, Series A, AA, M, and NC Preferred owned.","Record date is February 3, 2026; payable on or about February 9, 2026.","Dividend payable in authorized but unissued Series A Preferred stock.","All shareholders of record as of Record Date will receive the dividend on a 1:1 basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002956","json":"https://secwatch.observer/filing/0001493152-26-002956.json","markdown":"https://secwatch.observer/filing/0001493152-26-002956.md","text":"https://secwatch.observer/filing/0001493152-26-002956.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226002956/0001493152-26-002956-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226002956/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:18:08.838984+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}